Journal of pain and symptom management · 2026
Managing Use of Propofol for Refractory Symptoms in End-of-Life Care: Creating an Institutional Guideline.
СтатьяКлинические рекомендацииНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bartlett Christi, Brooks Joanna Veazey, Stoltzfus Ky, Parker Marilyn
Аннотация
BACKGROUND: End of life (EOL) care in hospitals is increasingly complex as patients are often critically ill and medically unstable. Propofol can be an important tool in treating refractory symptoms during EOL care to ensure comfort and prevent suffering during the dying process.
INTERVENTION: We aimed to define and standardize institutional practices for using propofol to manage refractory symptoms during EOL care. Using expert opinions, consensus building, and a microsystems team approach, we defined parameters for propofol use in managing refractory symptoms. We developed a flow diagram to guide decision making for propofol use during EOL care.
OUTCOMES: We developed a flow diagram as a decision-making tool that reduced confusion and hesitancy about the appropriate use of propofol for refractory symptoms during EOL care.
CONCLUSION/LESSONS LEARNED: Using a multidisciplinary process, we standardized an institutional approach for use of propofol in managing refractory symptoms during EOL care in hospital.
INTERVENTION: We aimed to define and standardize institutional practices for using propofol to manage refractory symptoms during EOL care. Using expert opinions, consensus building, and a microsystems team approach, we defined parameters for propofol use in managing refractory symptoms. We developed a flow diagram to guide decision making for propofol use during EOL care.
OUTCOMES: We developed a flow diagram as a decision-making tool that reduced confusion and hesitancy about the appropriate use of propofol for refractory symptoms during EOL care.
CONCLUSION/LESSONS LEARNED: Using a multidisciplinary process, we standardized an institutional approach for use of propofol in managing refractory symptoms during EOL care in hospital.